SCHEMBL3786216

SCHEMBL3786216

COc1ccc(OC(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.71
ALDH1A1 P00352 4/20 0.71
GAA P10253 1/20 0.71
HTT P42858 1/20 0.71
ATM Q13315 1/20 0.63
MEN1 O00255 6/20 0.61
KMT2A Q03164 6/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
NPC1 O15118 4/20 0.58
RAB9A P51151 3/20 0.58
MAPT P10636 3/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C19 P33261 2/20 0.58
LMNA P02545 2/20 0.58
TP53 P04637 1/20 0.58
CYP3A4 P08684 1/20 0.58
PKM P14618 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
MAPK1 P28482 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10192035 0.87 KMT2A (0.55) SMN1; SMN2ALDH1A1GAAHTTATM
SCHEMBL3786021 0.85 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1GAAHTTATM
SCHEMBL12407138 0.85 SMN1; SMN2 (0.73) SMN1; SMN2ALDH1A1GAAHTTMEN1
Phenyl 4-Methoxyphenylcarbamate SCHEMBL11183948 0.85 ALDH1A1 (0.90) SMN1; SMN2ALDH1A1GAAHTTMEN1
SCHEMBL4112669 0.84 NPC1 (0.81) SMN1; SMN2ALDH1A1HTTMEN1KMT2A
SCHEMBL2829063 0.84 PTGS2 (0.68) SMN1; SMN2ALDH1A1GAAHTTMEN1
SCHEMBL9618331 0.84 PTGS2 (0.68) SMN1; SMN2ALDH1A1GAAHTTMEN1
SCHEMBL97442 0.83 GAA (0.51) SMN1; SMN2ALDH1A1GAAHTTATM
SCHEMBL94538 0.83 SMN1; SMN2 (0.71) SMN1; SMN2ALDH1A1GAAHTTMEN1
SCHEMBL22204354 0.83 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1GAAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 SMN1; SMN2 4524/4885ALDH1A1 4339/4885GAA 1755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.